Medically reviewed by Anju Goel, MD A calcium blood test measures the calcium level in your blood. This test is typically ...

StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Sunday morning. The firm issued a sell rating on the biopharmaceutical ...

Here the authors show the structures of single-pass transmembrane receptor guanylyl cyclase in both apo and hormone-bound states, advancing our understanding of cross-membrane signaling by single ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical Trial Ongoing for SEP-786, Oral Small Molecule ...

Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical Trial Ongoing for SEP-786, Oral Small Molecule ...

The air pollutants are more than just a respiratory hazard; they also interfere with bone density and mineral composition ...

Wells Fargo analyst Derek Archila initiated coverage of Septerna (SEPN) with an Overweight rating and $43 price target The firm believes there ...

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

Another asset, MBX 1416 targeting Post-Bariatric Hypoglycemia [PBH], is in a phase 1 trial. Other candidates are preclinical. Lead asset MBX 2109 is a parathyroid hormone peptide prodrug. A prodrug, ...

A Gastroenterologist at Ohio State Wexner Medical Center on Thursday refuted an inaccurate claim made by the Chief Minister ...